StockGlow

MabCure, Inc. (MBCI)

Develops antibody tests to detect cancer early and create cancer treatments.

$0.00+0.00%Technology
Compare MBCI with
StockGlow Score
25
Leaning Bearish
BearishBullish
1 year ago+200.0%

The outlook

MBCI is trading well below both its 50- and 200-day moving averages and sits in the lower portion of its 52-week range. The overall sentiment leans bearish. Analyst coverage appears limited or unavailable for this micro-cap stock.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range39% of the way from its 52-week low to high
Market cap
$156
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

AMNPAmerican Sierra Gold Corp.$0.10-4.76%VNTAVentana Global Inc.$0.03+0.00%ALMEAlamo Energy Corp.$0.00+0.00%URBFUrban Barns Foods Inc.$0.00+0.00%LBYELiberty Energy Corp.$0.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy